13F-HR filed by Pivotal bioVenture Partners Investment Advisor LLC
Pivotal bioVenture Partners Investment Advisor LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-13, with 13 holding rows worth $394,215,626.
- Accession
- 0001012975-24-000075
- Filer
- CIK 1844645
- Filed
- 2024-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 13 entries on the cover page, a total value of $394,215,626 stated on the cover page (in dollars after the unit check, H1), rows summing to $394,215,626 with VALUE read as dollars as filed, 13F file number 028-20630. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerPivotal bioVenture Partners Fund I U.G.P. Ltd028-20631
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 797,008 | $252,261,002 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 793,036 | $49,802,661 | dollars as filed | |
| OCULIS HOLDING AG | H5870P102 | CMN | 1,888,788 | $21,211,089 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 4,494,851 | $19,148,065 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 1,560,982 | $15,001,037 | dollars as filed | |
| GRACELL BIOTECHNOLOGIES INC | 38406L103 | ADR | 1,375,000 | $13,805,000 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 1,910,009 | $6,169,329 | dollars as filed | |
| RALLYBIO CORP | 75120L100 | COM | 2,404,644 | $5,747,099 | dollars as filed | |
| EXSCIENTIA PLC | 30223G102 | ADS | 770,500 | $4,938,905 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 1,891,467 | $2,118,443 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 560,595 | $1,894,811 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 864,197 | $1,624,690 | dollars as filed | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 743,215 | $493,495 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-24-000075 | this filing | 2024-02-13 | acceptance time not in the bulk data set |